Related Experiment Videos
Serious adverse reactions in a tuberculosis programme setting in Kyrgyzstan
S G Hinderaker1, J Ysykeeva, J Veen
1Centre for International Health, University of Bergen, Bergen, Norway. Sven.Hinderaker@cih.uib.no
Summary
Serious adverse reactions during tuberculosis treatment are common, with most occurring early. Pyrazinamide and rifampicin were the most frequent causes of treatment interruption in Kyrgyzstan.
Area of Science:
- Clinical Medicine
- Pharmacology
- Infectious Diseases
Background:
- Tuberculosis (TB) remains a significant global health challenge.
- Effective TB treatment regimens are crucial for patient outcomes.
- Understanding adverse drug reactions (ADRs) is vital for treatment adherence.
Purpose of the Study:
- To investigate the incidence and characteristics of serious adverse reactions in new smear-positive tuberculosis patients.
- To identify common causative agents of adverse reactions during TB treatment.
- To determine the timing of adverse reactions in relation to treatment initiation.
Main Methods:
- A prospective study was conducted in a program setting in Kyrgyzstan.
- Smear-positive tuberculosis patients initiating treatment were monitored.
- Incidence of serious adverse reactions leading to treatment interruption (>=1 week) was recorded.
Main Results:
- Two percent of patients interrupted tuberculosis treatment due to adverse reactions.
- Over 80% of these reactions occurred within the first month of treatment.
- Pyrazinamide was identified as the most common cause, followed by rifampicin.
Conclusions:
- Serious adverse reactions frequently necessitate treatment interruption in new smear-positive TB patients.
- Early treatment monitoring is critical, as most reactions manifest within the first month.
- Pyrazinamide and rifampicin are key drugs to monitor for adverse events in this population.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...